Common use of Conduct of Studies Clause in Contracts

Conduct of Studies. ▇▇▇▇▇▇ shall conduct the post-marketing clinical studies required by Regulatory Authorities for the Product in the Field in the ▇▇▇▇▇▇ Territory which shall follow the clinical study plan which shall be attached hereto as Exhibit 8.1(a) (collectively, the “Clinical Studies”). Promptly following the execution of this Agreement, the Parties shall meet in good faith to draft Exhibit 8.1(a) based upon input from both of the Parties and the FDA (as applicable) and complete such exhibit as promptly as possible. Upon completion of the exhibit, it shall be acknowledged as the final exhibit in writing by both Parties and at such time shall be attached hereto and incorporated herein by reference. Kamada shall be obligated to use its Best Efforts to provide the related support required for Regulatory Approval for the continued marketing of the Product in the ▇▇▇▇▇▇ Territory. In connection therewith, the Parties shall at all times during the conduct of the Clinical Studies keep each other reasonably informed of all activities thereunder, and consult with each other as reasonably requested by the other Party. The JSC (as hereinafter defined) shall determine each Party’s responsibilities with respect to all Clinical Studies, provided that ▇▇▇▇▇▇ shall be responsible for the conduct of all Clinical Studies. ▇▇▇▇▇▇ shall comply with all laws and regulations applicable to the conduct of such Clinical Studies.